Sleep apnea is a person sleeping, the upper respiratory tract (including the nasopharynx, the oropharynx and the larynx) occurs repeatedly collapsed, and thus blocking the respiratory tract, resulting in breathing becomes shallow and laborious, and more severe cases can cause complete blockage of the airway, resulting in the inhalation of air and asphyxia. In severe cases, the airway can be completely blocked, resulting in no air intake and suffocation.
Negative Pressure Sleep Apnea Treatment Devices are thin, lightweight, and portable
Dr. Chen Zhongzhu, founder of Leiming Medical Devices, is a sleep apnea sufferer himself, and because he suffers from sleep apnea and understands the inconvenience of the current treatment devices, he has developed the Negative Pressure Sleep Apnea Treatment Devices (NPSATDs) technology, which uses negative pressure to keep the patient's jaw or tongue open and the upper airway open. Mainly utilizing negative pressure to maintain the patient's jaw or tongue in a position where the upper airway is open, unlike the forced insufflation of the traditional positive pressure sleep apnea assist device (CPAP), it has the advantages of natural breathing, comfort and quietness, thin and lightweight, and can be recharged using batteries to take with you wherever you go. On the contrary, according to statistics more than half of CPAP users give up the use of CPAP for sleep apnea treatment because of various reasons such as uncomfortable dosing, inability to adapt, and not easy to carry. In addition, the company is currently conducting multinational multi-center clinical trials and applying for multinational regulatory approvals, and has begun its global sales and marketing campaigns, with priority given to the European and East Asian markets.
Unique negative pressure respiratory arrest treatment device technology, continue to improve product performance and efficiency, the implementation of product design, the product has been awarded the Ministry of Economic Affairs and the Ministry of Health and Welfare of the drug science and technology research and development awards, but also selected for the 2016 German iF Design Award and Italy A' Design Award, and was awarded the 2016 outstanding The company has also been selected for the 2016 iF Design Award in Germany and the A' Design Award in Italy, and has won the 2016 Outstanding Biotech Industry Award - Innovation of the Year and the 2016 Taipei Biotech Award - New Technology Award. The company is also working on new products such as APP sleep monitoring and cloud services, as well as 3D scanning and printing application development, in order to provide customers with the best service and create the most value for the society.
Topics: Sleep Apnea